Coronary Artery Bypass Graft (CABG) Devices Market By Number Of Coronary Arteries (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery), By Types Of Devices (On-Pump Coronary Artery Bypass Devices, Off-Pump Coronary Artery Bypass Devices, Endoscopic Vessel Harvesting Devices, Anastomosis Assist Devices, Transmyocardial Revascularization Devices) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 24, 2016

Key Findings


The global coronary artery bypass graft devices market is expected to grow at the CAGR of 6.4 % during 2016-2022. Coronary artery bypass graft (CABG) is the most common type of heart surgery that is performed to treat people suffering from severe coronary artery and angina heart disease. In coronary heart disease, plaque is formed inside the coronary artery that transmits oxygenated blood to myocardium. As the plaque gets harder over the time, which subsequently narrows down the artery causing reduced blood flow to heart leading to chest pain called angina. In CABG, a healthy vein or artery from other part of the body is grafted to jam the coronary artery that facilitates the flow of oxygenated blood to heart muscles. Subject to the number of coronary arteries bypassed, the surgery is referred as quadruple bypass, triple bypass, double bypass and single bypass. Frequently, there are two different methods to perform CABG namely off-pump CABG and on-pump CABG. Some minimally invasive coronary artery bypass (MIDCAB) surgeries are also accomplished such as thoracoscopic or endoscopic and robotic assisted surgery that include less bleeding, low risk of infection, smaller incision, and reduced time of recovery. Some of the commercially available devices used in CABG are Ultima OPCAB system by Guidant, OPTrac STILLSITE stabilizer by Heartport and OCTOPUS 2+ tissue stabilization system by Medtronics. Some of the prominent dealers operating in this market are Heratport, MAQUET, Guidant, Medtronic, Sorin Group, and Terumo.


Industry experts forecast that the market for global coronary artery bypass graft devices market will primarily be boosted by increasing incidences of coronary heart diseases majorly due to unhealthy lifestyle and to some extent due to introduction of devices which are used in minimally invasive procedures such as Da Vinci system marketed by Intuitive Surgical, Inc. Rising use of anastomosis assist devices and endoscopic vessel harvesting devices, is also anticipated to support the growth of this market. According to WHO, in 2014, approximately 19.75 million people died due to cardiovascular diseases and among these around 9.3 million deaths were due to coronary heart disease. WHO also suggested that this death toll will keep on rising and will become 25.3 million by 2030. The main challenges before the market are matured markets of Europe and North America and the availability of minimally invasive alternative options such as percutaneous coronary interventions.


Market Segment Insight


The global coronary artery bypass graft devices market is majorly segmented into number of coronary arteries, types of devices and regional outlook. The number of coronary arteries market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery and quadruple CABG surgery.This depends on the number of stenosis the patient is suffering from. In types of devices segment, market is divided in to on-pump coronary artery bypass devices, off-pump coronary artery bypass devices, endoscopic vessel harvesting devices, anastomosis assist devices and Trans myocardial revascularization devices. An on-pump coronary artery bypass devices procedure needs heart-lung machine or cardiopulmonary bypass, whereas off-pump coronary artery bypass devices procedures are held in the absence of heart-lung machines. An off-pump coronary artery bypass device is relatively newer technology and is anticipated to be the fastest growing segment in the next six years.
In regional outlook, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North American region is having maximum market shares owing to rising coronary arteries diseases. Asia Pacific and European region is growing at an impressive rate, owing to increasing geriatric population.


Regional Insight


Globally, the global coronary artery bypass graft devices market is divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global coronary artery bypass graft devices market, owing to rising prevalence of cardiovascular diseases majorly due to unhealthy lifestyle, technological advancement and rising healthcare budget. Europe market is anticipated to gain volumes due to rising numbers of coronary diseases. Owing to the increase in medical tourism industry and growth in per capita income in Asian countries, the Asia-Pacific market is anticipated to flourish in the forecast time period. China is projected to be the fastest growing market for these devices attributed to the increasing access of public with healthcare professional and expanding economy. Rest of the world is showing positive growth rate as technology is advancing in this region.


Competitive Insights


Some of the key market players are Arterial Remodeling Technologies, Abbott Vascular, Kyoto medical planning, Boston Scientific, Biosensors International, B. Braun Melsungen, Sahajanand medical technologies, OrbusNeich Medical company, MicroPort Scientific, etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

CHAP 1. METHODOLOGY & SCOPE 13
1.1. RESEARCH METHODOLOGY 13
1.2. RESEARCH SCOPE & ASSUMPTIONS 13
1.3. LIST OF DATA SOURCES 13


CHAP 2. EXECUTIVE SUMMARY 14
2.1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SUMMARY & KEY BUYING CRITERIA 14
2.2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET OUTLOOK 14
2.3. MARKET SEGMENTATION ANALYSIS 14
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
2.5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET VALUE CHAIN ANALYSIS 14
2.6. VENDOR LANDSCAPE 14


CHAP 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET 15
3.1. MARKET DRIVER ANALYSIS 15
3.1.1. INCREASING CORONARY ARTERY DISEASE PREVALENCE 15
3.1.2. GLOBAL INCREASE IN HEALTHCARE EXPENDITURES 15
3.2. MARKET RESTRAINT ANALYSIS 15
3.2.1. POOR HEALTHCARE REIMBURSEMENT AND PAYMENT MODELS 15
3.3. KEY OPPORTUNITIES 15
3.3.1. GROWING USE OF ENDOSCOPIC VESSEL HARVESTING DEVICES 15
3.3.2. INCREASING GERIATRIC POPULATION BASE 15
3.4. CHALLENGES 15
3.4.1. HIGH COST OF CORONARY ARTERY BYPASS GRAFT DEVICES 15
3.4.2. LACK OF AWARENESS REGARDING CORONARY ARTERY BYPASS GRAFT DEVICES 15


CHAP 4. INDUSTRY ANALYSIS 16
4.1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET– PORTER’S FIVE FORCE MODEL 16
4.2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET– PESTEL ANALYSIS 16
4.3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET– GAP ANALYSIS 16


CHAP 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY NUMBER OF CORONARY ARTERIES 2012-2022 ($ MILLION) 17
5.1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY SINGLE CABG SURGERY 2012-2022 ($ MILLION) 17
5.2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY DOUBLE CABG SURGERY 2012-2022 ($ MILLION) 17
5.3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TRIPLE CABG SURGERY 2012-2022 ($ MILLION) 17
5.4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY QUADRUPLE CABG SURGERY 2012-2022 ($ MILLION) 17


CHAP 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TYPES OF DEVICES 2012-2022 ($ MILLION) 18
6.1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ON-PUMP CORONARY ARTERY BYPASS DEVICES 2012-2022 ($ MILLION) 18
6.2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY OFF-PUMP CORONARY ARTERY BYPASS DEVICES 2012-2022 ($ MILLION) 18
6.3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ENDOSCOPIC VESSEL HARVESTING DEVICES 2012-2022 ($ MILLION) 18
6.4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ANASTOMOSIS ASSIST DEVICES 2012-2022 ($ MILLION) 18
6.5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TRANSMYOCARDIAL REVASCULARIZATION DEVICES 2012-2022 ($ MILLION) 18


CHAP 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 19
7.1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY REGION 2012-2022 ($ MILLION) 19
7.2. NORTH AMERICA 19
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.2.3.1. U.S. 19
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3.2. CANADA 19
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.2.3.3. MEXICO 19
7.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3. EUROPE 20
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.3.3.1. GERMANY 20
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.2. UK 20
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.3. FRANCE 20
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.4. SPAIN 20
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.3.3.5. ITALY 20
7.3.3.5.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.3.3.5.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.3.3.6. REST OF EUROPE 21
7.3.3.6.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 21
7.3.3.6.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4. ASIA PACIFIC 21
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.4.3.1. CHINA 21
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3.2. INDIA 21
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3.3. JAPAN 21
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.4.3.4. SOUTH KOREA 21
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.4.3.5. REST OF APAC 22
7.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5. REST OF THE WORLD 22
7.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
7.5.3.1. LATIN AMERICA 22
7.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.5.3.2. MIDDLE EAST AND AFRICA 22
7.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22


CHAP 8. COMPETITIVE LANDSCAPE 23
8.1. ABBOTT VASCULAR 24
8.1.2. SCOT ANALYSIS 24
8.1.3. PRODUCT BENCHMARKING 24
8.1.4. STRATEGIC INITIATIVES 24
8.2. ARTERIAL REMODELING TECHNOLOGIES 24
8.2.2. SCOT ANALYSIS 24
8.2.3. PRODUCT BENCHMARKING 24
8.2.4. STRATEGIC INITIATIVES 24
8.3. B. BRAUN MELSUNGEN 24
8.3.2. SCOT ANALYSIS 24
8.3.3. PRODUCT BENCHMARKING 24
8.3.4. STRATEGIC INITIATIVES 24
8.4. BIOSENSORS INTERNATIONAL 24
8.4.2. PRODUCT BENCHMARKING 24
8.4.3. STRATEGIC INITIATIVES 24
8.5. BOSTON SCIENTIFIC 24
8.5.2. SCOT ANALYSIS 24
8.5.3. PRODUCT BENCHMARKING 24
8.5.4. STRATEGIC INITIATIVES 24
8.6. GUIDANT 24
8.6.2. SCOT ANALYSIS 24
8.6.3. PRODUCT BENCHMARKING 25
8.6.4. STRATEGIC INITIATIVES 25
8.7. HERATPORT 25
8.7.2. SCOT ANALYSIS 25
8.7.3. PRODUCT BENCHMARKING 25
8.7.4. STRATEGIC INITIATIVES 25
8.8. KYOTO MEDICAL PLANNING 25
8.8.2. SCOT ANALYSIS 25
8.8.3. PRODUCT BENCHMARKING 25
8.8.4. STRATEGIC INITIATIVES 25
8.9. MAQUET 25
8.9.2. SCOT ANALYSIS 25
8.9.3. PRODUCT BENCHMARKING 25
8.9.4. STRATEGIC INITIATIVES 25
8.10. MEDTRONIC 25
8.10.2. SCOT ANALYSIS 25
8.10.3. PRODUCT BENCHMARKING 25
8.10.4. STRATEGIC INITIATIVES 25
8.11. MICROPORT SCIENTIFIC 25
8.11.2. SCOT ANALYSIS 25
8.11.3. PRODUCT BENCHMARKING 25
8.11.4. STRATEGIC INITIATIVES 25
8.12. ORBUSNEICH MEDICAL COMPANY 26
8.12.2. SCOT ANALYSIS 26
8.12.3. PRODUCT BENCHMARKING 26
8.12.4. STRATEGIC INITIATIVES 26
8.13. SAHAJANAND MEDICAL TECHNOLOGIES 26
8.13.2. SCOT ANALYSIS 26
8.13.3. PRODUCT BENCHMARKING 26
8.13.4. STRATEGIC INITIATIVES 26
8.14. SORIN 26
8.14.2. SCOT ANALYSIS 26
8.14.3. PRODUCT BENCHMARKING 26
8.14.4. STRATEGIC INITIATIVES 26
8.15. TERUMO 26
8.15.2. SCOT ANALYSIS 26
8.15.3. PRODUCT BENCHMARKING 26
8.15.4. STRATEGIC INITIATIVES 26

TABLE 1 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY NUMBER OF CORONARY ARTERIES 2012-2022 ($ MILLION) 26
TABLE 2 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY SINGLE CABG SURGERY 2012-2022 ($ MILLION) 26
TABLE 3 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY DOUBLE CABG SURGERY 2012-2022 ($ MILLION) 26
TABLE 4 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TRIPLE CABG SURGERY 2012-2022 ($ MILLION) 27
TABLE 5 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY QUADRUPLE CABG SURGERY 2012-2022 ($ MILLION) 27
TABLE 6 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TYPES OF DEVICES 2012-2022 ($ MILLION) 27
TABLE 7 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ON-PUMP CORONARY ARTERY BYPASS DEVICES 2012-2022 ($ MILLION) 27
TABLE 8 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY OFF-PUMP CORONARY ARTERY BYPASS DEVICES 2012-2022 ($ MILLION) 27
TABLE 9 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ENDOSCOPIC VESSEL HARVESTING DEVICES 2012-2022 ($ MILLION) 27
TABLE 10 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY ANASTOMOSIS ASSIST DEVICES 2012-2022 ($ MILLION) 27
TABLE 11 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY TRANSMYOCARDIAL REVASCULARIZATION DEVICES 2012-2022 ($ MILLION) 27
TABLE 12 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 27
TABLE 13 GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET BY REGION 2012-2022 ($ MILLION) 27
TABLE 14 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 15 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 16 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
TABLE 17 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 18 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 19 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 20 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 21 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 22 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 23 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 24 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 25 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 26 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 27 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 28 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 29 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 30 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 31 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 32 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 33 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 34 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 35 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 36 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 28
TABLE 37 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 38 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 39 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 40 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 41 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 42 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 43 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 44 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 45 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 46 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 47 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 48 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 49 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 50 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 51 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 52 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 53 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 54 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 55 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 56 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 57 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 30
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)